16 | Metal-Organic FrameworksIBA
01/2021
-
04/2014 |
14 | PolymersIBA
01/2022
-
01/2012 |
13 | 1-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2021
-
12/2014 |
10 | Pharmaceutical PreparationsIBA
01/2022
-
01/2012 |
9 | Immune Checkpoint InhibitorsIBA
01/2022
-
12/2016 |
9 | Cisplatin (Platino)FDA LinkGeneric
11/2016
-
09/2008 |
6 | LigandsIBA
06/2020
-
03/2012 |
5 | Photosensitizing Agents (Photosensitizers)IBA
11/2021
-
12/2014 |
5 | Therapeutic UsesIBA
10/2020
-
03/2015 |
5 | Reactive Oxygen Species (Oxygen Radicals)IBA
06/2020
-
12/2014 |
4 | Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2022
-
01/2013 |
4 | B7-H1 AntigenIBA
01/2022
-
01/2018 |
4 | Carboplatin (JM8)FDA LinkGeneric
11/2021
-
01/2013 |
4 | MetalsIBA
01/2021
-
01/2017 |
4 | Small Interfering RNA (siRNA)IBA
01/2021
-
04/2014 |
4 | PlatinumIBA
01/2017
-
05/2009 |
3 | DNA (Deoxyribonucleic Acid)IBA
01/2022
-
08/2015 |
3 | LipidsIBA
01/2022
-
01/2012 |
3 | pyrithione zinc (ZPT)FDA Link
01/2022
-
12/2016 |
3 | ProdrugsIBA
01/2022
-
01/2015 |
3 | Neoplasm Antigens (Tumor Antigens)IBA
11/2021
-
01/2020 |
3 | AldosteroneIBA
11/2021
-
01/2019 |
3 | AntigensIBA
01/2021
-
01/2016 |
3 | tributyl phosphate (TBP)IBA
01/2020
-
01/2018 |
2 | Biological ProductsIBA
01/2021
-
07/2017 |
2 | Hydroxyl RadicalIBA
04/2020
-
01/2020 |
2 | ReninIBA
01/2020
-
01/2019 |
2 | AntibodiesIBA
01/2020
-
01/2016 |
2 | MicroRNAs (MicroRNA)IBA
01/2019
-
01/2017 |
2 | GemcitabineFDA Link
11/2016
-
03/2015 |
2 | Antineoplastic Agents (Antineoplastics)IBA
07/2016
-
08/2015 |
2 | chlorinIBA
01/2016
-
06/2015 |
2 | polysilsesquioxaneIBA
01/2015
-
10/2011 |
2 | Diphosphonates (Bisphosphonates)IBA
12/2014
-
03/2012 |
2 | Contrast MediaIBA
10/2013
-
12/2011 |
2 | Lipid Bilayers (Lipid Bilayer)IBA
03/2012
-
01/2012 |
2 | Peptides (Polypeptides)IBA
03/2012
-
12/2011 |
1 | EsterasesIBA
01/2022 |
1 | artenimol (dihydroartemisinin)IBA
01/2022 |
1 | LDL Lipoproteins (beta Lipoproteins)IBA
01/2022 |
1 | IronIBA
01/2022 |
1 | Blood Proteins (Serum Proteins)IBA
01/2022 |
1 | dimethylaminomicheliolideIBA
01/2022 |
1 | Type I DNA Topoisomerases (Topoisomerase I)IBA
01/2022 |
1 | CholesterolIBA
01/2022 |
1 | oxidized low density lipoproteinIBA
01/2022 |
1 | LDL Receptors (LDL Receptor)IBA
01/2022 |
1 | zinc 1,4,8,11,15,18,22,25- octa- n- butoxyphthalocyanineIBA
10/2021 |
1 | AcidsIBA
01/2021 |
1 | Neutralizing AntibodiesIBA
01/2021 |
1 | EndostatinsIBA
01/2021 |
1 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 |
1 | DigitoxinFDA Link
01/2021 |
1 | Messenger RNA (mRNA)IBA
01/2021 |
1 | VaccinesIBA
10/2020 |
1 | Pathogen-Associated Molecular Pattern MoleculesIBA
10/2020 |
1 | Oxygen (Dioxygen)IBA
04/2020 |
1 | CatalaseIBA
04/2020 |
1 | Imiquimod (Aldara)FDA LinkGeneric
01/2020 |
1 | OligodeoxyribonucleotidesIBA
01/2020 |
1 | Toll-Like Receptor 7IBA
01/2020 |
1 | Immunologic Adjuvants (Immunologic Adjuvant)IBA
01/2020 |
1 | Singlet OxygenIBA
01/2020 |
1 | Cancer VaccinesIBA
01/2020 |
1 | InterferonsIBA
01/2020 |
1 | Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
01/2020 |
1 | Superoxides (Superoxide)IBA
01/2020 |
1 | Estradiol (Delestrogen)FDA LinkGeneric
07/2019 |
1 | Hormones (Hormone)IBA
07/2019 |
1 | CateninsIBA
01/2019 |
1 | Carbon DioxideIBA
01/2019 |
1 | Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
01/2018 |